Literature DB >> 7389206

Cell cycle-specific effects of glucocorticoids on phytohaemagglutinin-stimulated lymphocytes.

J C Sloman, P A Bell.   

Abstract

Effects of steroid hormones and colchicine on the response of pig lymphocytes to phytohaemagglutinin (PHA) were assessed by measurement of [6-3H]thymidine incorporation. At steroid concentrations of 1 microM and below, only glucocorticoids and progesterone inhibited PHA-stimulated [6-3H]thymidine incorporation but at 100 microM inhibition was also produced by oestrogens, androgens and physiologically inactive steroids. Measurement of [6-3H]thymidine incorporation 18-24 hr, 6-12 hr or 0-6 hr after the delayed addition of the synthetic glucocorticoid, dexamethasone, to PHA-stimulated lymphocytes revealed a succession of alternating phases of sensitivity and insensitivity to the effects of the steroid which suggested that it was acting, perhaps indirectly, in a cell cycle stage-specific manner to arrest the progression of activated lymphocytes from G1 to S. Similar effects were observed with colchicine, but 100 microM 11-epicortisol inhibited [6-3H]thymidine incorporation in a non-cycle-specific manner. Glucocorticoid receptor levels in pig lymphocytes were increased 2-5-fold within 24 hr of PHA stimulation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389206      PMCID: PMC1538077     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Effect of prednisolone on cell-mediated cytotoxicity in vitro. Demonstration of a short sensitive induction phase.

Authors:  C J Sanderson; D Franks
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Effect of dexamethasone on cell population kinetics in the adrenal cortex of the prepubertal male rat.

Authors:  N A Wright; D R Appleton; A R Morley
Journal:  J Endocrinol       Date:  1974-09       Impact factor: 4.286

3.  Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone.

Authors:  S Segal; I R Cohen; M Feldman
Journal:  Science       Date:  1972-03-10       Impact factor: 47.728

4.  Action of a steroid anti-inflammatory agent (methylprednisolone) on the cell cycle: study on synchronized cells.

Authors:  M Adolphe; P Lechat
Journal:  Biomedicine       Date:  1974-01

5.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

6.  Effect of hydrocortisone, adrenalin and actinomycin D on transition of cells to the DNA synthesis phase.

Authors:  O S Frankfurt
Journal:  Exp Cell Res       Date:  1968-09       Impact factor: 3.905

7.  Effect of cortisone acetate on 19S and 7S haemolysin antibody. A time course study.

Authors:  E V Elliott; N R Sinclair
Journal:  Immunology       Date:  1968-11       Impact factor: 7.397

8.  Effect of prednisolone on synthesis of DNA and RNA by human lymphocytes in vitro.

Authors:  D C Tormey; H H Fudenberg; R M Kamin
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

9.  Inhibition by colchicine of the mitogenic stimulation of lymphocytes prior to the S phase.

Authors:  J L Wang; G R Gunther; G M Edelman
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

10.  Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction.

Authors:  I R Cohen; L Stavy; M Feldman
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

View more
  2 in total

1.  Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.

Authors:  R M Gledhill; A J Edwards; M R Norman
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

2.  Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.

Authors:  Burak Durmaz; Bakiye Goker Bagca; Ozgur Cogulu; Sunde Yilmaz Susluer; Araz Alpay; Serap Aksoylar; Cumhur Gunduz
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.